Non-alcoholic fatty liver disease (NAFLD) and type 2 diabetes mellitus (T2DM) are closely associated, and liver fibrosis has been related to macrovascular complications. We examined whether liver fibrosis, diagnosed by FibroScan® , correlates with chronic vascular complications in a cohort of T2DM
BackgroundNon-alcoholic fatty liver disease (NAFLD) is increasingly widespread with an overall globa...
Cardiovascular disease (CVD) is the leading cause of death among patients with nonalcoholic fatty li...
AimDespite the high prevalence and serious clinical implications of non-alcoholic fatty liver diseas...
Background & Aims: Non-alcoholic fatty liver disease (NAFLD) and type 2 diabetes mellitus (T2DM)...
Background & Aims: Non-alcoholic fatty liver disease (NAFLD) and type 2 diabetes mellitus (T2DM)...
Abstract BACKGROUND & AIMS: Non-alcoholic fatty liver disease (NAFLD) and type 2 diabetes mell...
BACKGROUND & AIMS: Non-alcoholic fatty liver disease (NAFLD) and type 2 diabetes mellitus (T2DM...
The aim of the study was to determine the relationship between the degree of progression of liver fi...
The aim of the study was to determine the relationship between the degree of progression of liver fi...
Liver fibrosis is a key pathophysiology process in chronic liver disease. It is still unclear whethe...
Background and aim: Cardiovascular disease (CVD) is the principal cause of death in patients with ty...
AIM Non-alcoholic fatty liver disease (NAFLD) and type 2 diabetes mellitus (T2DM) have a synergis...
BACKGROUND & AIMS: Patients with non-alcoholic fatty liver disease (NAFLD) are at increased chan...
AIM: Despite the high prevalence and serious clinical implications of non-alcoholic fatty liver dise...
Introduction: Metabolic dysfunction associated fatty liver disease (MAFLD) was suggested recently as...
BackgroundNon-alcoholic fatty liver disease (NAFLD) is increasingly widespread with an overall globa...
Cardiovascular disease (CVD) is the leading cause of death among patients with nonalcoholic fatty li...
AimDespite the high prevalence and serious clinical implications of non-alcoholic fatty liver diseas...
Background & Aims: Non-alcoholic fatty liver disease (NAFLD) and type 2 diabetes mellitus (T2DM)...
Background & Aims: Non-alcoholic fatty liver disease (NAFLD) and type 2 diabetes mellitus (T2DM)...
Abstract BACKGROUND & AIMS: Non-alcoholic fatty liver disease (NAFLD) and type 2 diabetes mell...
BACKGROUND & AIMS: Non-alcoholic fatty liver disease (NAFLD) and type 2 diabetes mellitus (T2DM...
The aim of the study was to determine the relationship between the degree of progression of liver fi...
The aim of the study was to determine the relationship between the degree of progression of liver fi...
Liver fibrosis is a key pathophysiology process in chronic liver disease. It is still unclear whethe...
Background and aim: Cardiovascular disease (CVD) is the principal cause of death in patients with ty...
AIM Non-alcoholic fatty liver disease (NAFLD) and type 2 diabetes mellitus (T2DM) have a synergis...
BACKGROUND & AIMS: Patients with non-alcoholic fatty liver disease (NAFLD) are at increased chan...
AIM: Despite the high prevalence and serious clinical implications of non-alcoholic fatty liver dise...
Introduction: Metabolic dysfunction associated fatty liver disease (MAFLD) was suggested recently as...
BackgroundNon-alcoholic fatty liver disease (NAFLD) is increasingly widespread with an overall globa...
Cardiovascular disease (CVD) is the leading cause of death among patients with nonalcoholic fatty li...
AimDespite the high prevalence and serious clinical implications of non-alcoholic fatty liver diseas...